Immune checkpoint ligands, such as PD-L1 expressed by infected or malignant cells, can interact with immune checkpoint receptors on T cells, which further inhibits the immune response and stimulates the immune evasion of virus or tumor cells (32). The gene discussed is CD274; the disease is neoplasm.